16-01-2020

16-01-2020

01 E. Fita - Pulmonary hypertension.

01 E. Fita - Pulmonary hypertension.

02 S. Ioannou - Evaluation of PCI in SCLC: single center experience.

02 S. Ioannou - Evaluation of PCI in SCLC: single center exp...

03 M. Mitsogianni - Immunotherapy in non-small cell lung cancer: current approach and future perspectives.

03 M. Mitsogianni - Immunotherapy in non-small cell lung can...

04 Discussion

05 I. Kotteas - Optimizing outcomes and treatment sequences in EGFR mutation-positive non-small-cell lung cancer.

05 I. Kotteas - Optimizing outcomes and treatment sequences...

06 G. Evangelou - Guidelines for the management of advanced-metastatic NSCLC without targetable mutations.

06 G. Evangelou - Guidelines for the management of advanced-...

07 I. Gkiozos - Screening for lung cancer.

07 I. Gkiozos - Screening for lung cancer.

08 M. Kouvela - Are there reliable biomarkers for early detection of lung cancer?

08 M. Kouvela - Are there reliable biomarkers for early dete...

09 Discussion

10 M. Kiagia - The arrivals of biosimilars.

10 M. Kiagia - The arrivals of biosimilars.

11 G. Kounadis - The clinical significance of microbiome.

11 G. Kounadis - The clinical significance of microbiome.

12 M. Bakogeorgos - Optimal management of leptomeningeal spread.

12 M. Bakogeorgos - Optimal management of leptomeningeal spr...

13 Discussion

14 G. Gourzoulidis - End-of-life cost for lung cancer patients.

14 G. Gourzoulidis - End-of-life cost for lung cancer patien...

15 E. Kokkotou - Advanced NSCLC patients, real-world treatment patterns and outcomes.

15 E. Kokkotou - Advanced NSCLC patients, real-world treatme...

2024 2023 2022 2021 2020 2019 2018 2017 2016

livemed white